(Q37874154)

24 August 2017

1 reference

title

Estrogen and thrombosis: controversies and common sense (English)

1 reference

24 August 2017

0 references

Thomas G DeLoughery

1

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Reviews in Endocrine and Metabolic Disorders

24 August 2017

published in

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

77-84

1 reference

Estrogens, progestogens and thrombosis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Contraceptive hormone use and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Prescribing oral contraceptives for women older than 35 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Controversies in contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Range of published estimates of venous thromboembolism incidence in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Epidemiology of the contraceptive pill and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

The use of newer progestins for contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Risk of venous thromboembolism with drospirenone in combined oral contraceptive products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

ORTHO EVRA and venous thromboembolism: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Oral contraceptives and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Oral contraception and thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Mechanisms of estrogen-induced venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Venous thromboembolism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Postmenopausal hormone therapy and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Thrombosis in pregnancy: maternal and fetal issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Thrombophilia, clinical factors, and recurrent venous thrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Risk assessment for recurrent venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Probable drug interaction between warfarin and hormonal contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9178-0

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

21 January 2018

1 reference

12 December 2020

Oral contraceptives and venous thromboembolism

1 reference

12 December 2020

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

1 reference

12 December 2020

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

1 reference

12 December 2020

Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol

1 reference

12 December 2020

Hormone therapy and thromboembolic disease

1 reference

12 December 2020

Oral contraceptives and the risk of myocardial infarction

1 reference

12 December 2020

Third-generation oral contraceptives: how risky?

1 reference

12 December 2020

The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women

1 reference

12 December 2020

Metabolic effects of contraceptive steroids

1 reference

12 December 2020

Hormones and cardiovascular health in women

1 reference

12 December 2020

Venous thromboembolic disease and pregnancy

1 reference

12 December 2020

Oral administration of methylergometrine shows a late and unpredictable effect on the non-pregnant human menstruating uterus

1 reference

12 December 2020

Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives

1 reference

12 December 2020

Menstrual regulation in women with von Willebrand's disease

1 reference

12 December 2020

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

1 reference

12 December 2020

The risk of deep venous thrombosis with oral contraceptives containing drospirenone

1 reference

12 December 2020

Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)

1 reference

12 December 2020

Surrogate end points in women's health research: science, protoscience, and pseudoscience

1 reference

12 December 2020

10.1007/S11154-011-9178-0

Identifiers

DOI

1 reference

24 August 2017

1 reference